Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 9/20 | 0.36 |
| ▸ | SIK1 | P57059 | 2/20 | 0.36 |
| ▸ | SIK2 | Q9H0K1 | 2/20 | 0.36 |
| ▸ | SIK3 | Q9Y2K2 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.35 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23960949 | 0.76 | SIRT6 (0.46) | NPC1RAB9AKMT2AMAPT | |
| SCHEMBL23536740 | 0.75 | CHRNB2 (0.48) | NPC1RAB9AKMT2A | |
| Hydrochloric Acid SCHEMBL25241141 | 0.74 | CHRNB2 (0.47) | NPC1RAB9AKMT2A | |
| SCHEMBL14889617 | 0.73 | SMO (0.41) | CNR2MAPK1 | |
| SCHEMBL26115242 | 0.72 | OPRK1 (0.40) | NPC1RAB9AKMT2ALRRK2HRH3 | |
| SCHEMBL15709817 | 0.72 | AOC3 (0.38) | CNR2SIK1SIK2SIK3KMT2A | |
| SCHEMBL31561318 | 0.70 | PLK1 (0.36) | SIK1SIK2SIK3NPC1RAB9A | |
| SCHEMBL30535282 | 0.70 | PLK1 (0.36) | SIK1SIK2SIK3NPC1RAB9A | |
| SCHEMBL10328696 | 0.70 | CYP4F2 (0.44) | CYP4F2CYP4A11NPC1RAB9AKMT2A | |
| SCHEMBL30667961 | 0.70 | RBP4 (0.36) | CNR2KCNQ3KCNQ2NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260035361-A1 | COMPOUNDS FOR MODULATING HUR (ELAVL1) | SHANGHAI DEGRON BIOMEDICAL TECH CO LTD (CN) | 2026-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035361-A1 | COMPOUNDS FOR MODULATING HUR (ELAVL1) | ELAVL1, ELAVL3, HNRNPL | CYP4F2 2922/4885CYP4A11 2352/4885CNR2 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.